CJC-1295 DAC:GHRF - short for drug affinity complex:growth hormone-releasing factor), is a synthetic analogue of growth hormone-releasing hormone (GHRH) (also known as growth hormone-releasing factor (GRF)) and a growth hormone secretagogue (GHS). The mechanism of action is focused on enhancing the stimulation of the growth hormone release in the blood. At the same time the process itself takes place without disturbing the natural pulse-like curve. In simple terms, CJC-1295 DAC, unlike the peptides of the GHRP group, releases growth hormone evenly in small quantities without sudden jumps of GH in the blood.
100% Original from the Chinese Nanox.
Manufacturer and product photo may vary.
All packs are air tight sealed and expire up to 10.2021.
CJC-1295 with DAC is a synthetic analogue of a Growth Hormone Secretagogue (GHS) and Growth Hormone-Releasing Hormone (GHRH). It can be classified as the tetra-substituted peptide hormones and contains thirty amino acids. CJC-1295 is an improved formula of GRF (1-29), with a modified half-life.
The peptide significantly raises insulin-like growth factor 1 (IGF-1) and plasma growth hormone (GH) levels in humans and animals. Medical studies have revealed that the use of CJC-1295 may increase body weight, increase growth hormone, and total pituitary RNA. The increase in growth hormone and total pituitary RNA proposes that extra growth hormone-producing cells are made.
Although both CJC-1295 (DAC) and CJC-1295 (GRF 1-29) belong to the same peptides class, the later stimulates the body to produce its own growth hormone. It has last longer in the blood than its counterpart as it can last up to two weeks.
According to several clinical studies, the peptide provides the binding of CJC-1295 DAC albumin and plasma proteins that results in an increased effect. Moreover, the effect is also enhanced by the influence of lysine guaranteed with Drug Affinity Complex (DAC).
An improved GRF 1-29 CJC 1295 builds a thirty minutes half-life while CJC-1295 with DAC offers a 6-8 days outcome, which is perfect for two times in weekly doses. Medical studies have shown that within six days after the first injection, the levels of growth hormone plasma increases in 2-10 times.
Similarly, within 9-11 days after the first dose, the concentration of IGF-1 increases in 1.5-3 times. By effectiveness the preparation is equivalent to the sequence of growth hormone of 15 IU per day, proving an actual democratic price.
Size of vile - 2mg. The initial dose becomes ineffective by the 5th day and hence one should administer it two times per week to sustain optimal concentration. 1000-2000mcg two times per week is the recommended dosage.
The cycle period of CJC-1295 DAC is between 8 and 12 weeks hence one should adopt a two weeks break. If one is 40 years old and above only one injection should be administered in a week. This dose should be administered at bedtime.
To maintain optimum concentration it is necessary to carry out injections 2 times per week (since by the fifth day it falls to ineffective). The recommended dosage equals 1000-2000mcg, 2 times a week.
Negative side effects may include tingling, numbness, decreased insulin, and water retention. Other side effects associated with the use of the peptide CJC 1295 DAC may include itching, tiredness, head rush, and a feeling of lethargy.
The positive side effects are faster recovery, reduces body fat, increases protein synthesis, increases lean body mass, bone density promotion, and cellular stimulation for skin cells and internal organs.
The MHRA and FDA has not evaluated or endorsed this product. Please consult your physician prior to using this or any other nutritional supplements or medications.
Should be stored in the at 2-8 degrees Celsius. Do not freeze.
Keep away from direct sunlight. Keep locked and away from children.
Ask us any questions about CJC-1295 DAC.